PTJ
GDRX icon

Paul Tudor Jones’s GoodRx Holdings GDRX Stock Holding History

Paul Tudor Jones’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,900
Closed -$25.3K – 3828
2026
Q1 		$25.3K Sell
12,900
-39,400
-75% -$92.4K ﹤0.01% 3502
2025
Q4 		$142K Buy
+52,300
New +$172K ﹤0.01% 3348

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Paul Tudor Jones's GDRX Position: Q3 2025 in Review

Paul Tudor Jones sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 24,086 shares — an estimated $120K sold.

Paul Tudor Jones first reported a position in GDRX in Q3 2020 and held it in 16 quarters. The position peaked at $12.4M in Q3 2020. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Paul Tudor Jones reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 24,086 GoodRx Holdings shares in Q3 2025, an estimated $120K.
  • Paul Tudor Jones first reported a position in GoodRx Holdings in Q3 2020 and held it in 16 quarters.
  • Paul Tudor Jones's GoodRx Holdings position peaked at $12.4M in Q3 2020.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.